Janelle Romero
Physician Assistant · Phoenix, AZNPI 1689901860
Payments from drug & device makers
Across 291 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$982
- GSK$592
- Pfizer$507
- Boehringer Ingelheim$409
- Lilly USA, LLC$363
- plus $2K from 31 others
What the payments were for
- Food & beverage$6,31697%
- Education$1743%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $1,150 |
| Novo Nordisk | 41 | $982 |
| GSK | 25 | $592 |
| Pfizer | 22 | $507 |
| Boehringer Ingelheim | 18 | $409 |
| Lilly USA, LLC | 22 | $363 |
| Astellas Pharma US Inc | 9 | $344 |
| AstraZeneca | 18 | $289 |
| Exact Sciences | 12 | $264 |
| Boston Scientific | 2 | $198 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $169 |
| Abbott | 7 | $143 |
| Amgen | 7 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Eisai Inc. | 4 | $94 |
| Lucid Diagnostics Inc. | 3 | $90 |
| Merck | 4 | $66 |
| Novartis | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Biohaven Pharmaceuticals, Inc. | 4 | $55 |
| Amarin Pharma, Inc. | 3 | $46 |
| Nestle Healthcare Nutrition Inc. | 2 | $40 |
| Indivior Inc. | 1 | $40 |
| Bayer | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Grifols USA, LLC | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Phadia US Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Ardelyx, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$360
- WATCHMAN FLX$172
- AREXVY$125
- UBRELVY$122
- VRAYLAR$120
- SHINGRIX$116
- NURTEC ODT$110
- ZAVZPRET$103
How this compares
$6,490 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $96,886 |
| MounjaroTirzepatide | 58 | $67,358 |
| FarxigaDapagliflozin Propanediol | 26 | $32,434 |
| JardianceEmpagliflozin | 20 | $29,146 |
| JanuviaSitagliptin Phosphate | 23 | $28,385 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $22,349 |
| TrulicityDulaglutide | 20 | $21,655 |
| BelsomraSuvorexant | 31 | $14,303 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $10,408 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,277 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $6,315 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $4,976 |
| LantusInsulin Glargine,hum.Rec.Anlog | 11 | $3,946 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $3,154 |
| Gabapentin | 121 | $2,574 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $982 | $96,88671 claims |
| Lilly USA, LLCMounjaro, Trulicity | $363 | $89,01378 claims |
| MerckJanuvia, Belsomra | $66 | $42,68854 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $409 | $39,55335 claims |
| AstraZenecaFarxiga, Symbicort | $289 | $38,74941 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $592 | $29,62531 claims |
| Sanofi-aventis U.S. LLCLantus | $18 | $3,94611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Phoenix
- Alyssa BoschenPhoenix$86K
- Katherine MinorPhoenix$76K
- Micah LasleyPhoenix$52K
- Thomas SirrinePhoenix$37K
- Karla HortonPhoenix$36K
- Larissa AnthonyPhoenix$32K
- Tana FrumentoPhoenix$25K
- Rosemary SrisukPhoenix$17K
- John DorseyPhoenix$17K
- Kendall SmithPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.